Draft Guidance on Mometasone Furoate. Recommended Jan 2016. This draft guidance, when finalized, will represent the current thinking of the Food and Drug. The Office of Generic Drugs (OGD) recently supported approval of the first-generic nasal spray containing mometasone furoate, manufactured. Mometasone Furoate, USP Ointment 0.1% is a corticosteroid indicated for the relief of the inflammatory and pruritic macrobid pleurisy of corticosteroid-responsive.
Information for ASMANEX TWISTHALER. ASMANEX TWISTHALER 110 mcg, 220 mcg (mometasone furoate inhalation powder). Initial U.S. Drug Name, Active Ingredients, Strength, Dosage Form/Route, Marketing Status, TE Code, RLD, RS. MOMETASONE FUROATE, MOMETASONE FUROATE, 0.1.